Ying Zhang, M.D. M.S. Ph.D.

Ying 1637453842813628418

Associate Professor
Director, Center for American Indian Health Research

Department of Biostatistics and Epidemiology

Phone: (405) 271-2229, ext 48073
Office: The University of Oklahoma Health Sciences Center
801 Northeast 13th Street, Room 303
Post Office Box 26901
Oklahoma City, Oklahoma 73126-0901
Email: Ying-Zhang4@ouhsc.edu

Education and Training:

  • Post-Doctoral Training, University of Oklahoma Health Sciences Center.
  • Ph.D. in Biostatistics, West China University of Medical Sciences, Chengdu, Sichuan, China.
  • M.S. in Biostatistics, West China University of Medical Sciences, Chengdu, Sichuan, China.
  • M.D. in Preventive Medicine, West China University of Medical Sciences, Chengdu, Sichuan, China.

Appointments and Positions:

  • July 2017 – Present: Associate Professor, Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center.
  • October 2012 – June 2017: Assistant professor of Research, Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center.
  • August, 2005 – September, 2012: Assistant professor of Research, Center for American Indian Health Research, Hudson College of Public Health, University of Oklahoma Health Sciences Center.
  • July 1994 – August 1999: Lecturer, Department of Health Statistics, School of Public Health, West China University of Medical Sciences, Chengdu, Sichuan, China

Courses Taught:

  • BSE 5163: Biostatistics Methods I
  • BSE 5173: Biostatistics Methods II
  • BSE 5663: Analysis of Frequency Data

Complete List of Publications:

https://www.ncbi.nlm.nih.gov/myncbi/1Dewhy-2PGdAs/bibliography/public/

Most Recent 5 Publications:

  • Suchy-Dicey AM, Zhang Y, McPherson S, Tuttle R, Howard BV, Umans JG, Buchwald DS. . Glomerular filtration function decline, mortality, and cardiovascular events: data from the Strong Heart Study. Kidney360. Nov. 2020; doi: https://doi.org/10.34067/KID.0000782020.
  • Muller CJ, Alonso A, Forster J, Vock DM, Zhang Y, Gottesman RF, Rosamond W, Longstreth WT Jr, MacLehose RF. Stroke Incidence and Survival in American Indians, Blacks, and Whites: The Strong Heart Study and Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2019 Jun 18;8(12):e010229. doi: 10.1161/JAHA.118.010229. Epub 2019 Jun 13. PubMed PMID: 31189396; PubMed Central PMCID: PMC6645631.
  • Basu A, Jenkins AJ, Stoner JA, Zhang Y, Klein RL, Lopes-Virella MF, Garvey WT, Schade DS, Wood J, Alaupovic P, Lyons TJ. Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D. J Lipid Res. 2018 May;59(5):872-883. doi: 10.1194/jlr.P080143. Epub 2018 Mar 25. PubMed PMID: 29576550; PubMed Central PMCID: PMC5928427.
  • Lee JS, Chang PY, Zhang Y, Kizer JR, Best LG, Howard BV. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study. Diabetes Care. 2017 Apr;40(4):529-537. doi: 10.2337/dc16-1958. Epub 2017 Jan 25. PubMed PMID: 28122840; PubMed Central PMCID: PMC5360283.
  • Zhang Y, Jenkins AJ, Basu A, Stoner JA, Lopes-Virella MF, Klein RL, Lyons TJ. Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes. J Lipid Res. 2016 Feb;57(2):310-7. doi: 10.1194/jlr.P060657. Epub 2015 Dec 9. PubMed PMID: 26658239; PubMed Central PMCID: PMC4727426.

Research Interest:

  • Time-to-event and longitudinal data analyses for independent or correlated outcomes, categorical data analysis, model building, study design and sample size, genetic epidemiology and pathophysiology of cardio-metabolic diseases, especially among American Indians.

Current Research Projects:

  • Collaborative Cohort of Cohorts for COVID-19 Research (C4R) (2020-2022)
    • This is a nationwide study of more than 50,000 individuals to determine factors that predict disease severity and long-term health impacts of COVID-19.
  • Strong Heart Study (SHS) Phase VII (2019-2026): https://strongheartstudy.org/
    • The SHS is a study of cardiovascular disease and its risk factors among American Indian men and women supported by the National Heart, Lung, and Blood Institute (NHLBI) since October 1, 1988 and is the largest epidemiologic study of American Indians ever undertaken.
    • Phase VII is currently underway and includes continued surveillance beginning February 2019 for a seven-year duration. Support for a basic follow-up examination of approximately 3,500 participants during the Phase VII contract cycle will be included. The SHS Phase VII exam will serve as a platform for in-depth ancillary studies that are funded outside of the SHS contracts. These ancillary studies will be operationally integrated into the main study, and can propose additional exam components.
  • Protecting Privacy and Facilitating Shared Access of Clinical and Genetic Data of Special Populations (2017-2022)
    • This study aims to develop advanced technologies and scientific computing toolkits to enable shared, but protected, data access to SHS data, as well as to study the data sharing preferences of SHS participants. The approaches will abide by SHS Tribal sovereignty and agreements that include Tribal review and approval of all SHS data use requests.